Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
ABSI Stock — Absci Corporation
Absci Corporation (ABSI)
Updated October 16, 2026.
ABSI is a Stock. Total return is -61.8% over the past 5.2 years, 149.8 points behind SPY at 88.0%.
Absci Corporation is a clinical-stage biopharmaceutical company developing antibody-based therapeutic treatments for inflammatory bowel disease, androgenic alopecia, immuno-oncology, and oncology indications. The company collaborates with research institutions and technology partners including Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Oracle Corporation on drug development programs. As an early-stage biotech company, Absci does not currently distribute to shareholders, making it oriented toward investors seeking potential long-term capital appreciation rather than current income.
ABSI performance versus SPY
Price and return data through 2026-10-16.
Total return is -61.8% over the past 5.2 years, 149.8 points behind SPY at 88.0%. Over the past year its total return — price change plus distributions reinvested — is 69.4%. Its deepest 1-year drawdown was 52.8%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | 2.6% | — |
| 3M | 0.2% | — |
| 6M | 155.4% | — |
| YTD | 136.4% | — |
| 1Y | 69.4% | — |
| 2Y CAGR | — | 41.40% |
| 3Y CAGR | — | 79.30% |
| 5Y CAGR | — | -4.90% |
| Since inception (5.2 years) | -61.8% | -16.80% |
ABSI key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 07/22/2021
- Distribution frequency
- None
- Last close
- $8.25 (as of 2026-10-16)
- Market cap
- $1,415,815,582
- Average volume
- 3533624.0
- Beta
- 2.28
- Payout ratio
- 0.0%
- EPS
- $-0.79
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
ABSI risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 52.8%.
Who may consider ABSI — and who may not
It is a weaker fit for investors who need monthly cash flow (ABSI does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on ABSI
Frequently asked questions
Does ABSI pay monthly?
No. ABSI does not currently distribute.
When does ABSI pay a dividend?
ABSI does not currently distribute.
How has ABSI performed?
Total return is -61.8% over the past 5.2 years, 149.8 points behind SPY at 88.0%. Over the past year its total return — price change plus distributions reinvested — is 69.4%. Its deepest 1-year drawdown was 52.8%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.